Verheyen, N., & März, W. (2017). Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism: The randomized, placebo-controlled EPATH trial. Bone, 105, . https://doi.org/10.1016/j.bone.2017.08.030
Chicago-Zitierstil (17. Ausg.)Verheyen, Nicolas, und Winfried März. "Effect of Eplerenone on Markers of Bone Turnover in Patients with Primary Hyperparathyroidism: The Randomized, Placebo-controlled EPATH Trial." Bone 105 (2017). https://doi.org/10.1016/j.bone.2017.08.030.
MLA-Zitierstil (9. Ausg.)Verheyen, Nicolas, und Winfried März. "Effect of Eplerenone on Markers of Bone Turnover in Patients with Primary Hyperparathyroidism: The Randomized, Placebo-controlled EPATH Trial." Bone, vol. 105, 2017, https://doi.org/10.1016/j.bone.2017.08.030.